OPTN (Option Therapeutics) FCF Margin %: 0.00% (As of Dec. 2025)


What is Option Therapeutics FCF Margin %?

Option Therapeutics OPTN FCF Margin % is 0.00% as of Dec. 2025.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Option Therapeutics's Free Cash Flow for the three months ended in Dec. 2025 was $-0.28 Mil. Option Therapeutics's Revenue for the three months ended in Dec. 2025 was $0.00 Mil. Therefore, Option Therapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Option Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Option Therapeutics's FCF Margin % or its related term are showing as below:


OPTN's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Option Therapeutics FCF Margin % Related Terms

Option Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics FCF Margin % Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
FCF Margin %
0.00 0.00

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

OPTN vs : FCF Margin % Comparison

For the Biotechnology subindustry, Option Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Option Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Option Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Option Therapeutics's FCF Margin % falls into.


Option Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Option Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.157/0
= %

Option Therapeutics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.28/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Option Therapeutics (OPTN) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' FCF Margin % too high?
Option Therapeutics' current FCF Margin % is 0.00%.
How does Option Therapeutics' FCF Margin % compare to ?
Option Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.